Founded in 2013 and based in Ann Arbor, Michigan, IROA Technologies specializes in providing carbon isotopes for the identification and analysis of chemical signatures in biological compounds. The company's core mission is to enhance the accuracy and reproducibility of metabolomics data through innovative products and technologies. Their offerings include labeled yeast, workflow kits, libraries for mass spectrometry, and kits for metabolic profiling, all designed to reduce noise, analytical variability, and ion suppression in metabolic profiling.

IROA Technologies has made significant strides in the field of metabolomics, with notable affiliations including partnerships with leading research institutions and industry experts. The company's key achievements include the development of the C13-labeled yeast metabolomics workflow and the IROA MLSDiscovery software, both of which have been instrumental in advancing metabolic profiling techniques. Overall, IROA Technologies has had a substantial impact on the scientific community by providing tools that lead to cleaner, more accurate datasets and better research outcomes.